Thrombospondin type 1 domain–containing 7A (THSD7A) is a target antigen identified in
adult membranous nephropathy (MN) along with the major antigen phospholipase A 2 …

Summary In 2019, the Kidney Diseases: Improving Global Outcomes guidelines recognized
anti-PLA2R antibodies (but not anti-THSD7A antibodies) as a valuable molecular risk factor …

Aim Serum levels of phospholipase A2 receptor antibody (PLA2R; SAb) and glomerular
deposits of PLA2R antigen (GAg) have been detected in patients with idiopathic …

Methods Patients. Fifty unrelated Japanese patients with IMN became the subjects of this
study. The diagnosis of IMN was made according to the histological criteria of Ehrenreich …

Background. Membranous glomerulonephropathy (MN) is the most prevalent cause of
nephrotic syndrome in adult humans. However, the specific biomarkers of MN have not been …

Rationale & Objective Proteinuria and anti–phospholipase A 2 receptor 1 (anti-PLA 2 R1)
antibody titers are associated with primary membranous nephropathy (MN) outcomes. We …

Background The anti-phospholipase A2 receptor (PLA2R) antibody is a non-invasive
diagnostic tool and prognosis predictor of idiopathic membranous nephropathy (IMN) …

Background Phospholipase A2 receptor antibodies (PLA2R-Ab) and thrombospondin type-1
domain-containing 7A antibodies (THSD7A-Ab) are present in 70–80% of patients with …

Background Idiopathic membranous nephropathy is an autoimmune disease. In
approximately 70% of patients, it is associated with autoantibodies against the …

Background Glomerular M‐type phospholipase A2 receptor (PLA2R) is important for
diagnosing idiopathic membranous nephropathy (IMN). The relation between glomerular …